VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
Xconomy
OCTOBER 1, 2018
VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.
Let's personalize your content